Basal Cell Carcinoma Aggressiveness, Molecular Factors And Therapy: A Clinician Perspective Cover

.blurhash-client-img { display: none !important; }

Basal Cell Carcinoma Aggressiveness, Molecular Factors And Therapy: A Clinician Perspective

ARS Medica Tomitana

Volume 18 (2012): Issue 2 (May 2012)

By: D. Dorobanţu, Mihaela Opriş, Georgeta Liliana Cif, C. Trâmbiţaş, L. Seres Sturm and E. B. Petcu

Open Access

|Feb 2013

Authors

D. Dorobanţu

University of Medicine and Pharmacy, Târgu Mureş, Romania

Mihaela Opriş

University of Medicine and Pharmacy, Târgu Mureş, Romania

Georgeta Liliana Cif

Mures County Hospital, Târgu Mureş, Romania

C. Trâmbiţaş

Mures County Hospital, Târgu Mureş, Romania

L. Seres Sturm

University of Medicine and Pharmacy, Târgu Mureş, Romania

E. B. Petcu

e.petcu@griffith.edu.au

University of Medicine and Pharmacy Târgu Mureş, Griffith University School of Medicine, Romania

DOI: https://doi.org/10.2478/v10307-012-0011-0 | Journal eISSN: 1841-4036 | Journal ISSN: 1223-9666

Journal RSS Feed

Language: English

Page range: 54 - 61

Published on: Feb 26, 2013

Published by: Ovidius University of Constanta

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

metastatic basal cell carcinoma,

5-Fluorouracil,

Related subjects:

Clinical medicine,

Clinical medicine, other

© 2013 D. Dorobanţu, Mihaela Opriş, Georgeta Liliana Cif, C. Trâmbiţaş, L. Seres Sturm, E. B. Petcu, published by Ovidius University of Constanta
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 18 (2012): Issue 2 (May 2012)Next article